Hong Kong's Hutchison Whampoa and China's Guangzhou Baiyunshan Pharmaceutical agreed to a 50-50 joint venture in Guangzhou to produce traditional Chinese medicines. Guangzhou's plant will be a major component of the deal, which one consultant said demonstrates the growing interest among overseas investments in traditional Chinese medicines.

Related Summaries